Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 100, Issue 10
Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical science
Changing from a
pro re nata
treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration
Online download statistics by month:
Online download statistics by month: January 2016 to February 2024
Abstract
Full
Pdf
Jan 2016
344
49
152
Feb 2016
126
26
49
Mar 2016
79
12
28
Apr 2016
64
19
22
May 2016
104
16
31
Jun 2016
307
9
23
Jul 2016
56
7
19
Aug 2016
101
22
21
Sep 2016
538
30
73
Oct 2016
993
30
97
Nov 2016
244
25
117
Dec 2016
171
5
25
Jan 2017
110
13
17
Feb 2017
80
21
27
Mar 2017
83
32
25
Apr 2017
49
13
11
May 2017
62
23
17
Jun 2017
58
30
20
Jul 2017
72
8
12
Aug 2017
123
20
16
Sep 2017
229
23
15
Oct 2017
390
15
21
Nov 2017
247
32
17
Dec 2017
156
34
9
Jan 2018
160
24
7
Feb 2018
113
24
5
Mar 2018
153
27
7
Apr 2018
99
29
11
May 2018
138
18
3
Jun 2018
80
20
4
Jul 2018
86
28
5
Aug 2018
86
25
2
Sep 2018
79
28
4
Oct 2018
104
18
9
Nov 2018
83
17
6
Dec 2018
86
17
4
Jan 2019
64
18
7
Feb 2019
89
20
14
Mar 2019
74
2
3
Apr 2019
68
13
12
May 2019
71
13
5
Jun 2019
45
19
5
Jul 2019
77
17
4
Aug 2019
52
20
3
Sep 2019
67
23
9
Oct 2019
62
17
5
Nov 2019
78
17
3
Dec 2019
54
16
2
Jan 2020
55
15
4
Feb 2020
65
20
5
Mar 2020
55
18
3
Apr 2020
51
24
3
May 2020
56
25
4
Jun 2020
101
18
14
Jul 2020
100
19
8
Aug 2020
53
21
7
Sep 2020
75
15
1
Oct 2020
62
18
9
Nov 2020
52
2
1
Dec 2020
89
0
1
Jan 2021
57
3
2
Feb 2021
71
3
6
Mar 2021
73
3
1
Apr 2021
37
3
1
May 2021
27
7
2
Jun 2021
6
1
3
Jul 2021
1
1
3
Aug 2021
4
4
3
Sep 2021
11
8
8
Oct 2021
31
3
3
Nov 2021
32
4
3
Dec 2021
25
1
1
Jan 2022
50
6
9
Feb 2022
42
4
5
Mar 2022
58
0
0
Apr 2022
32
2
1
May 2022
69
4
0
Jun 2022
73
3
5
Jul 2022
85
6
6
Aug 2022
73
5
0
Sep 2022
44
1
1
Oct 2022
79
5
3
Nov 2022
49
8
2
Dec 2022
47
1
0
Jan 2023
73
2
1
Feb 2023
87
4
0
Mar 2023
18
2
1
Apr 2023
27
4
0
May 2023
38
3
2
Jun 2023
38
2
2
Jul 2023
35
1
2
Aug 2023
42
2
1
Sep 2023
68
1
0
Oct 2023
162
4
2
Nov 2023
46
1
2
Dec 2023
46
1
0
Jan 2024
42
1
1
Feb 2024
16
1
0
Total
9482
1294
1145
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?